利用假型慢病毒颗粒进行CRISPR-Cas9的细胞特异性递送：只需更换包膜。 - Suppr

Suppr

超能文献

Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope.

作者信息

Covo-Vergara Ángela, Salaberry Laura, Silva-Pilipich Noelia, Hervas-Stubbs Sandra, Smerdou Cristian

机构信息

Division of Cancer, Cima Universidad de Navarra, Av. Pío XII 55, 31008 Pamplona, Spain.

Instituto de Investigación Sanitaria de Navarra (IdISNA) and CCUN, Pamplona, Spain.

出版信息

Mol Ther Nucleic Acids. 2024 Nov 27;35(4):102395. doi: 10.1016/j.omtn.2024.102395. eCollection 2024 Dec 10.

DOI:10.1016/j.omtn.2024.102395

PMID:39669702

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11634983/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28d9/11634983/52e108985cc9/gr1.jpg

相似文献

Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope.利用假型慢病毒颗粒进行CRISPR-Cas9的细胞特异性递送：只需更换包膜。

Mol Ther Nucleic Acids. 2024 Nov 27;35(4):102395. doi: 10.1016/j.omtn.2024.102395. eCollection 2024 Dec 10.

Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector.利用慢病毒载体改变的嗜性实现 CRISPR/Cas9 系统递送至肝肿瘤用于癌症治疗。

Biomaterials. 2021 May;272:120793. doi: 10.1016/j.biomaterials.2021.120793. Epub 2021 Apr 1.

The stability of envelope-pseudotyped lentiviral vectors.包膜假型慢病毒载体的稳定性。

Gene Ther. 2021 Feb;28(1-2):89-104. doi: 10.1038/s41434-020-00193-y. Epub 2020 Sep 24.

Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles.通过在假型慢病毒衍生纳米颗粒中递送CRISPR-Cas9核糖核蛋白复合物进行细胞靶向基因修饰

Mol Ther Nucleic Acids. 2024 Aug 31;35(4):102318. doi: 10.1016/j.omtn.2024.102318. eCollection 2024 Dec 10.

Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.使用展示抗CCR5单链抗体的辛德毕斯假型慢病毒载体进行细胞类型特异性靶向。

Hum Gene Ther. 2005 Feb;16(2):223-34. doi: 10.1089/hum.2005.16.223.

Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.用于CRISPR/Cas9递送的慢病毒载体的生产与验证

Methods Mol Biol. 2019;1961:93-109. doi: 10.1007/978-1-4939-9170-9_7.

Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.引入可切割的信号肽可提高以日本脑炎病毒包膜蛋白为假型的慢病毒载体的包装效率。

Virus Res. 2017 Feb 2;229:9-16. doi: 10.1016/j.virusres.2016.12.007. Epub 2016 Dec 16.

Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.用RD114-TR嵌合包膜糖蛋白假型化的慢病毒载体转导人造血干细胞。

Hum Gene Ther. 2007 Sep;18(9):811-20. doi: 10.1089/hum.2006.138.

Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping.逆转录病毒载体对超速离心的稳定性取决于用于假型化的病毒内核和包膜蛋白。

Mol Cells. 2017 May 31;40(5):339-345. doi: 10.14348/molcells.2017.0043. Epub 2017 May 2.

Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.用不同包膜蛋白假型化的慢病毒载体转导人原始重建造血细胞。

Mol Ther. 2010 Jul;18(7):1310-7. doi: 10.1038/mt.2010.48. Epub 2010 Apr 6.

引用本文的文献

Epigenome Engineering Using dCas Systems for Biomedical Applications and Biotechnology: Current Achievements, Opportunities and Challenges.利用dCas系统进行生物医学应用和生物技术的表观基因组工程：当前成果、机遇与挑战

Int J Mol Sci. 2025 Jul 2;26(13):6371. doi: 10.3390/ijms26136371.

本文引用的文献

Mol Ther Nucleic Acids. 2024 Aug 31;35(4):102318. doi: 10.1016/j.omtn.2024.102318. eCollection 2024 Dec 10.

A new breakthrough in genome editing: the story of Casgevy.基因组编辑的一项新突破：Casgevy的故事。

Cytotherapy. 2024 Nov;26(11):1299-1300. doi: 10.1016/j.jcyt.2024.06.003. Epub 2024 Jun 12.

Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification.用于递送支持碱基编辑、引导编辑和体内基因修饰的CRISPR/Cas核糖核蛋白复合物的工程化慢病毒衍生纳米颗粒（LVNPs）。

Nucleic Acids Res. 2023 Oct 13;51(18):10059-10074. doi: 10.1093/nar/gkad676.

Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease.用于镰状细胞病基因校正的Cas9蛋白递送非整合型慢病毒载体

Mol Ther Methods Clin Dev. 2021 Mar 3;21:121-132. doi: 10.1016/j.omtm.2021.02.022. eCollection 2021 Jun 11.

Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration.通过 CRISPR/Cas9 介导的靶向基因整合工程表达 α-PD-1 抗体的长寿浆细胞。

Cell Death Dis. 2020 Nov 12;11(11):973. doi: 10.1038/s41419-020-03187-1.

Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins.使用装载 Cas9-sgRNA 核糖核蛋白的病毒衍生的 Nanoblades 在原代细胞和体内进行基因组编辑。

Nat Commun. 2019 Jan 3;10(1):45. doi: 10.1038/s41467-018-07845-z.

Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction.用尼帕病毒包膜蛋白对第三代慢病毒载体进行假型化，用于血管内皮细胞转导的鉴定。

Gene Ther. 2013 Oct;20(10):997-1005. doi: 10.1038/gt.2013.23. Epub 2013 May 23.

Protein transduction by pseudotyped lentivirus-like nanoparticles.假型慢病毒样纳米颗粒的蛋白转导。

Gene Ther. 2011 Sep;18(9):936-41. doi: 10.1038/gt.2011.38. Epub 2011 Mar 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验